Consultant Haematologist, MPH Student, Pediatric Pulmonology, Vanderbilt University
Fellowship Site: Aminu Kano Teaching Hospital, Nigeria
Fellowship Project: Feasibility of secondary stroke prevention strategy in Children and Adults with Sickle Cell Disease in a Low Income Country using low dose Hydroxyurea Therapy.
Dr Najibah Galadanci is an attending hematologist with Aminu Kano Teaching Hospital , one of the largest tertiary care hospitals in Nigeria. Practicing as a hematologist in Kano, provided her with the opportunity to manage diverse hematological diseases with her main clinical and research interest in sickle cell disease (SCD). She received the David Satcher award for Masters degree in public health( Epidemiology track) at Vanderbilt University. She is currently the Site investigator for an NIH-funded R21 grant (1R21NS080639-01), a feasibility trial of hydroxyurea to prevent strokes in children with SCD.
Dr Galadanci’s career goals and objectives include
1. Develop the necessary tools required to initiate hypothesis-driven, patient-oriented research targeted on the prevention of the multiple complications of SCD.
2. To become a leader within the sickle cell disease community and contribute in promoting evidence-based strategies in the prevention and management of SCD complications, especially in developing world settings.